Home » Prices » NASDAQ:RCKT

Rocket Pharmaceuticals, Inc. stock price

Today's NASDAQ:RCKT chart, history & news

Price:
32.04 USD
Change:
+0 (0%)
Key Stats
Price open 31.37
Previous close 32.04
Market cap 1.77B
Volume 203.74K
Day high 33.19
Day low 31.12
Year high 34.68
Year low 9.71
Year to date change 40.77%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm's clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded in 1999 and is headquartered in New York, NY.

Company information

Company name
Rocket Pharmaceuticals Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
57
CEO
Gaurav Shah
Address
The Empire State Building, 350 5th Avenue Suite 7530, New York, NY, 10118
Country
United States
Contact information
1.646.440.9100
Website
http://www.rocketpharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.